Report cover image

Tissue and Organ Transplantation Industry Research Report 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 117 Pages
SKU # APRC20352399

Description

Summary

According to APO Research, The global Tissue and Organ Transplantation market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Tissue and Organ Transplantation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Tissue and Organ Transplantation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Tissue and Organ Transplantation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Tissue and Organ Transplantation include Arthrex, Biolife Solutions, Discovery Life Sciences, Medtronic, Stryker Corporation, Teva Pharmaceuticals, Veloxis Pharmaceutical, Zimmer Biomet and Abbvie and etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tissue and Organ Transplantation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tissue and Organ Transplantation.
The Tissue and Organ Transplantation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tissue and Organ Transplantation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Tissue and Organ Transplantation Segment by Company

Arthrex
Biolife Solutions
Discovery Life Sciences
Medtronic
Stryker Corporation
Teva Pharmaceuticals
Veloxis Pharmaceutical
Zimmer Biomet
Abbvie
Novartis
Tissue and Organ Transplantation Segment by Type

Preservation Solution
Immunosuppressive Drugs
Tissue Products
Tissue and Organ Transplantation Segment by Application

Hospital
Transplant Centers
Others
Tissue and Organ Transplantation Segment by Application

Hospital
Transplant Centers
Others
Tissue and Organ Transplantation Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tissue and Organ Transplantation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tissue and Organ Transplantation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tissue and Organ Transplantation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Tissue and Organ Transplantation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Table of Contents

117 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Tissue and Organ Transplantation by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Preservation Solution
2.2.3 Immunosuppressive Drugs
2.2.4 Tissue Products
2.3 Tissue and Organ Transplantation by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Hospital
2.3.3 Transplant Centers
2.3.4 Others
2.4 Assumptions and Limitations
3 Tissue and Organ Transplantation Breakdown Data by Type
3.1 Global Tissue and Organ Transplantation Historic Market Size by Type (2020-2025)
3.2 Global Tissue and Organ Transplantation Forecasted Market Size by Type (2026-2031)
4 Tissue and Organ Transplantation Breakdown Data by Application
4.1 Global Tissue and Organ Transplantation Historic Market Size by Application (2020-2025)
4.2 Global Tissue and Organ Transplantation Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Tissue and Organ Transplantation Market Perspective (2020-2031)
5.2 Global Tissue and Organ Transplantation Growth Trends by Region
5.2.1 Global Tissue and Organ Transplantation Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Tissue and Organ Transplantation Historic Market Size by Region (2020-2025)
5.2.3 Tissue and Organ Transplantation Forecasted Market Size by Region (2026-2031)
5.3 Tissue and Organ Transplantation Market Dynamics
5.3.1 Tissue and Organ Transplantation Industry Trends
5.3.2 Tissue and Organ Transplantation Market Drivers
5.3.3 Tissue and Organ Transplantation Market Challenges
5.3.4 Tissue and Organ Transplantation Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Tissue and Organ Transplantation Players by Revenue
6.1.1 Global Top Tissue and Organ Transplantation Players by Revenue (2020-2025)
6.1.2 Global Tissue and Organ Transplantation Revenue Market Share by Players (2020-2025)
6.2 Global Tissue and Organ Transplantation Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Tissue and Organ Transplantation Head Office and Area Served
6.4 Global Tissue and Organ Transplantation Players, Product Type & Application
6.5 Global Tissue and Organ Transplantation Manufacturers Established Date
6.6 Global Tissue and Organ Transplantation Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Tissue and Organ Transplantation Market Size (2020-2031)
7.2 North America Tissue and Organ Transplantation Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Tissue and Organ Transplantation Market Size by Country (2020-2025)
7.4 North America Tissue and Organ Transplantation Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Tissue and Organ Transplantation Market Size (2020-2031)
8.2 Europe Tissue and Organ Transplantation Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Tissue and Organ Transplantation Market Size by Country (2020-2025)
8.4 Europe Tissue and Organ Transplantation Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Tissue and Organ Transplantation Market Size (2020-2031)
9.2 Asia-Pacific Tissue and Organ Transplantation Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Tissue and Organ Transplantation Market Size by Country (2020-2025)
9.4 Asia-Pacific Tissue and Organ Transplantation Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Tissue and Organ Transplantation Market Size (2020-2031)
10.2 South America Tissue and Organ Transplantation Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Tissue and Organ Transplantation Market Size by Country (2020-2025)
10.4 South America Tissue and Organ Transplantation Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Tissue and Organ Transplantation Market Size (2020-2031)
11.2 Middle East & Africa Tissue and Organ Transplantation Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Tissue and Organ Transplantation Market Size by Country (2020-2025)
11.4 Middle East & Africa Tissue and Organ Transplantation Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Arthrex
12.1.1 Arthrex Company Information
12.1.2 Arthrex Business Overview
12.1.3 Arthrex Revenue in Tissue and Organ Transplantation Business (2020-2025)
12.1.4 Arthrex Tissue and Organ Transplantation Product Portfolio
12.1.5 Arthrex Recent Developments
12.2 Biolife Solutions
12.2.1 Biolife Solutions Company Information
12.2.2 Biolife Solutions Business Overview
12.2.3 Biolife Solutions Revenue in Tissue and Organ Transplantation Business (2020-2025)
12.2.4 Biolife Solutions Tissue and Organ Transplantation Product Portfolio
12.2.5 Biolife Solutions Recent Developments
12.3 Discovery Life Sciences
12.3.1 Discovery Life Sciences Company Information
12.3.2 Discovery Life Sciences Business Overview
12.3.3 Discovery Life Sciences Revenue in Tissue and Organ Transplantation Business (2020-2025)
12.3.4 Discovery Life Sciences Tissue and Organ Transplantation Product Portfolio
12.3.5 Discovery Life Sciences Recent Developments
12.4 Medtronic
12.4.1 Medtronic Company Information
12.4.2 Medtronic Business Overview
12.4.3 Medtronic Revenue in Tissue and Organ Transplantation Business (2020-2025)
12.4.4 Medtronic Tissue and Organ Transplantation Product Portfolio
12.4.5 Medtronic Recent Developments
12.5 Stryker Corporation
12.5.1 Stryker Corporation Company Information
12.5.2 Stryker Corporation Business Overview
12.5.3 Stryker Corporation Revenue in Tissue and Organ Transplantation Business (2020-2025)
12.5.4 Stryker Corporation Tissue and Organ Transplantation Product Portfolio
12.5.5 Stryker Corporation Recent Developments
12.6 Teva Pharmaceuticals
12.6.1 Teva Pharmaceuticals Company Information
12.6.2 Teva Pharmaceuticals Business Overview
12.6.3 Teva Pharmaceuticals Revenue in Tissue and Organ Transplantation Business (2020-2025)
12.6.4 Teva Pharmaceuticals Tissue and Organ Transplantation Product Portfolio
12.6.5 Teva Pharmaceuticals Recent Developments
12.7 Veloxis Pharmaceutical
12.7.1 Veloxis Pharmaceutical Company Information
12.7.2 Veloxis Pharmaceutical Business Overview
12.7.3 Veloxis Pharmaceutical Revenue in Tissue and Organ Transplantation Business (2020-2025)
12.7.4 Veloxis Pharmaceutical Tissue and Organ Transplantation Product Portfolio
12.7.5 Veloxis Pharmaceutical Recent Developments
12.8 Zimmer Biomet
12.8.1 Zimmer Biomet Company Information
12.8.2 Zimmer Biomet Business Overview
12.8.3 Zimmer Biomet Revenue in Tissue and Organ Transplantation Business (2020-2025)
12.8.4 Zimmer Biomet Tissue and Organ Transplantation Product Portfolio
12.8.5 Zimmer Biomet Recent Developments
12.9 Abbvie
12.9.1 Abbvie Company Information
12.9.2 Abbvie Business Overview
12.9.3 Abbvie Revenue in Tissue and Organ Transplantation Business (2020-2025)
12.9.4 Abbvie Tissue and Organ Transplantation Product Portfolio
12.9.5 Abbvie Recent Developments
12.10 Novartis
12.10.1 Novartis Company Information
12.10.2 Novartis Business Overview
12.10.3 Novartis Revenue in Tissue and Organ Transplantation Business (2020-2025)
12.10.4 Novartis Tissue and Organ Transplantation Product Portfolio
12.10.5 Novartis Recent Developments
13 Report Conclusion
14 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.